| Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program (NCT01032447) | Stanford University | 2010-01-01 |
| A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression (NCT01077726) | Hoffmann-La Roche | 2010-01-01 |
| Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy (NCT00994279) | Wake Forest University Health Sciences | 2010-01-01 |
| Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women (NCT01069211) | Korean Breast Cancer Study Group | 2010-01-01 |
| Evaluation of Radiation Induced Toxicity to the Heart by Multi-detector Computed Tomography (MDCT) (NCT01018719) | Western Galilee Hospital-Nahariya | 2010-01-01 |
| Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer (NCT01246427) | Centre Leon Berard | 2010-01-01 |
| Biomarkers in Blood Samples From Older Breast Cancer Survivors (NCT01138345) | UNC Lineberger Comprehensive Cancer Center | 2010-01-01 |
| Community Volunteers Promoting Physical Activity Among Cancer Survivors (NCT00948701) | The Miriam Hospital | 2010-01-01 |
| A Home-based Physical Activity Intervention in Breast Cancer Survivors (NCT02408107) | Dudley Group NHS Foundation Trust | 2010-01-01 |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel (NCT01050075) | City of Hope Medical Center | 2010-01-01 |
| Tissue Oxygenation Measurements With Modulated Light (S-FLARE) (NCT01116297) | Beth Israel Deaconess Medical Center | 2010-01-01 |
| PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer (NCT00774241) | Hoffmann-La Roche | 2010-01-01 |
| Evaluation the Diagnostic Ability of the Cancer Detection Technology (CDT) to Detect Breast Cancer Among Women Population Over Age 40 (NCT01043055) | Hadassah Medical Organization | 2010-01-01 |
| Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer (NCT01175694) | University Hospital Erlangen | 2010-01-01 |
| Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene (NCT01072318) | Korean Breast Cancer Study Group | 2010-01-01 |
| Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer (NCT01057069) | The Netherlands Cancer Institute | 2010-01-01 |
| An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer (NCT01215123) | Hoffmann-La Roche | 2010-01-01 |
| To Evaluate the Characteristics of a Breast Cancer (NCT01055678) | Mark Dewhirst | 2010-01-01 |
| The Attitudes, Communication, Treatment and Support Intervention to Reduce Breast Cancer Treatment Disparity (NCT01184066) | University of Pittsburgh | 2010-01-01 |
| Postoperative Analgesia Impact of Narcotic Free Anesthesia (NCT01544959) | Université de Sherbrooke | 2010-01-01 |
| Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models. (NCT07426653) | Florence Nightingale Hospital, Istanbul | 2010-01-01 |
| Cone Beam Computed Tomography for Breast Imaging (NCT01107860) | Koning Corporation | 2010-01-01 |
| Development of Predictive Biomarkers and Novel Approached to Therapy in Breast Cancer (NCT01051492) | National University Hospital, Singapore | 2010-01-01 |
| Acellular Dermal Matrix in Breast Reconstruction (NCT02835781) | University Hospital Bratislava | 2010-01-01 |
| Regenerative Tissue Matrix for Breast Reconstruction (NCT01027637) | Henry Ford Health System | 2010-01-01 |
| Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice (NCT01108315) | BrightOutcome | 2010-01-01 |
| BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease (NCT01070485) | Bayer | 2010-01-01 |
| Ethnic Predisposition, Risk Factors & Breast Cancer Presentation. (NCT05458570) | Bahria University | 2010-01-01 |
| X-Ray Mammography Standard of Care Protocol (NCT01052740) | National Institutes of Health Clinical Center (CC) | 2009-12-30 |
| Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients (NCT01027416) | Roswell Park Cancer Institute | 2009-12-14 |
| Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis (NCT01377363) | Spanish Breast Cancer Research Group | 2009-12-11 |
| Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 (NCT00622401) | Beth Israel Deaconess Medical Center | 2009-12-01 |
| Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases (NCT00949247) | Case Comprehensive Cancer Center | 2009-12-01 |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors (NCT01012362) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| Role of Beta-Endorphin in Cancer Therapy Fatigue (NCT01113905) | Massachusetts General Hospital | 2009-12-01 |
| Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the Breast (NCT01031238) | M.D. Anderson Cancer Center | 2009-12-01 |
| Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® (NCT01448447) | Mercy Research | 2009-12-01 |
| ELBA: Exemestane and Lapatinib in Advanced Breast Cancer (NCT01005641) | National Cancer Institute, Naples | 2009-12-01 |
| Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy (NCT01045044) | Kettering Health Network | 2009-12-01 |
| Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB (NCT01072838) | SenoRx, Inc. | 2009-12-01 |
| A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer (NCT01038804) | Astellas Pharma Inc | 2009-12-01 |
| Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies (NCT01041235) | Azaya Therapeutics, Inc. | 2009-12-01 |
| Investigation of Genetic Determinants of Capecitabine Toxicity (NCT00977119) | University of Chicago | 2009-11-23 |
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium (NCT00896454) | Amgen | 2009-11-16 |
| Cytokine Expression During Radiation for Breast Cancer (NCT00836186) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-11-13 |
| Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases (NCT01004172) | Dana-Farber Cancer Institute | 2009-11-01 |
| RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF (NCT01035099) | Weill Medical College of Cornell University | 2009-11-01 |
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer (NCT00859703) | Hospices Civils de Lyon | 2009-11-01 |
| ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer (NCT01009788) | Steven J Isakoff, MD, PhD | 2009-11-01 |
| Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer (NCT01007890) | Precision Therapeutics | 2009-11-01 |
| Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer (NCT01012440) | University of Chicago | 2009-11-01 |
| A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer (NCT00976989) | Hoffmann-La Roche | 2009-11-01 |
| Chemotherapy-Induced Peripheral Neuropathy Survey (NCT01016028) | M.D. Anderson Cancer Center | 2009-11-01 |
| Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer (NCT00916877) | Alberta Health services | 2009-11-01 |
| Effectiveness of a Decision Support System in Improving the Diagnosis and Screening Rate of Breast Cancer (NCT01336257) | Hospital Italiano de Buenos Aires | 2009-11-01 |
| Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up (NCT00929084) | Washington University School of Medicine | 2009-11-01 |
| Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer (NCT01530607) | King Faisal Specialist Hospital & Research Center | 2009-11-01 |
| Behavioral Intervention Study for Better Breast and Cervical Cancer Control for Korean American Women (NCT00857636) | Johns Hopkins University | 2009-11-01 |
| Specimen X-Rays of Removed Axillary Lymph Nodes to Guide Pathological Sampling (NCT01156454) | University of Arkansas | 2009-11-01 |
| MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer (NCT01231386) | City of Hope Medical Center | 2009-11-01 |
| Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer (NCT00903006) | M.D. Anderson Cancer Center | 2009-11-01 |
| Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding (NCT01004081) | Biogen | 2009-11-01 |
| Staging of Axillary Lymph Nodes Using the PEM Flex Solo II Pet Scanner in Patients With Breast Cancer (NCT01011946) | University of Chicago | 2009-11-01 |
| National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] (NCT01104935) | Comprehensive Support Project for Oncology Research | 2009-10-28 |
| Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation (NCT00930579) | Columbia University | 2009-10-16 |
| A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer (NCT00950300) | Hoffmann-La Roche | 2009-10-16 |
| Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms (NCT02118636) | Lynn Henry | 2009-10-01 |
| Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer) (NCT01167842) | University of Washington | 2009-10-01 |
| A Comparison of the 15 and 30 Acquisition Angle Breast Tomosynthesis Mammography for Breast Abnormalities (NCT00990483) | Hologic, Inc. | 2009-10-01 |
| Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer (NCT01024582) | The Netherlands Cancer Institute | 2009-10-01 |
| Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. (NCT01003158) | AstraZeneca | 2009-10-01 |
| Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy (NCT00956813) | Alliance for Clinical Trials in Oncology | 2009-10-01 |
| Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS) (NCT00500383) | University Health Network, Toronto | 2009-10-01 |
| 3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer (NCT00802711) | Cancer Trials Ireland | 2009-10-01 |
| Genomic Structural Variation in Cancer Susceptibility (NCT00996710) | Memorial Sloan Kettering Cancer Center | 2009-10-01 |
| Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer (NCT01031446) | Vanderbilt-Ingram Cancer Center | 2009-10-01 |
| Metabolic Changes as a Diagnostic Indicator for Cancer (NCT02362776) | Hasselt University | 2009-10-01 |
| Guilford Genomic Medicine Initiative (GGMI) (NCT01372553) | The Moses H. Cone Memorial Hospital | 2009-10-01 |
| Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors (NCT01482702) | University of Vermont | 2009-10-01 |
| Acupuncture for the Treatment of Chronic Lymphedema (NCT01003951) | Memorial Sloan Kettering Cancer Center | 2009-10-01 |
| Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen (NCT00984399) | Memorial Sloan Kettering Cancer Center | 2009-09-22 |
| A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer (NCT00984321) | Memorial Sloan Kettering Cancer Center | 2009-09-22 |
| STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) (NCT00887380) | Trans Tasman Radiation Oncology Group | 2009-09-16 |
| A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015) (NCT00963547) | Merck Sharp & Dohme LLC | 2009-09-15 |
| Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer (NCT00876395) | Novartis Pharmaceuticals | 2009-09-10 |
| Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer (NCT00976131) | Columbia University | 2009-09-01 |
| Fast Spectral Imaging Device for Tumor Margin Mapping (NCT01107080) | Duke University | 2009-09-01 |
| Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery (NCT00984490) | Vanderbilt-Ingram Cancer Center | 2009-09-01 |
| Preoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast Cancer (NCT01014715) | University of Maryland, Baltimore | 2009-09-01 |
| Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer (NCT01120158) | Hellenic Oncology Research Group | 2009-09-01 |
| Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT (NCT01664091) | Dana-Farber Cancer Institute | 2009-09-01 |
| F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer (NCT00992706) | Swiss Cancer Institute | 2009-09-01 |
| PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors (NCT01592825) | Martin-Luther-Universität Halle-Wittenberg | 2009-09-01 |
| Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer (NCT00981812) | University of Cincinnati | 2009-09-01 |
| STRIDE - STimulating Immune Response In aDvanced brEast Cancer (NCT00925548) | EMD Serono | 2009-09-01 |
| A Study of LY573636-sodium in Patients With Metastatic Breast Cancer (NCT00992225) | Eli Lilly and Company | 2009-09-01 |
| One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure (NCT00956384) | University Health Network, Toronto | 2009-09-01 |
| ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer (NCT00993642) | Tulane University Health Sciences Center | 2009-09-01 |
| Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer (NCT01896050) | University of Michigan Rogel Cancer Center | 2009-09-01 |
| A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery (NCT01929395) | Dartmouth-Hitchcock Medical Center | 2009-09-01 |